Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 4, 2002Expert Reviews in Molecular Medicine

Immunological hurdles in the path to gene therapy for Duchenne muscular dystrophy

View Full Paper
Ask AI
Bookmark
Share

Authors

DWDominic J. WellsRoyal Veterinary CollegeAFAurora FerrerKWKim E. WellsUniversity of London

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wells et al. (2002) studied this question.

synapsesocial.com/papers/6a7eae6a347a0bb3b2a6c766https://doi.org/10.1017/s146239940200515x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Myoblast transfer in duchenne muscular dystrophy1993 · 308 citations
  2. 2Expression of human full-length and minidystrophin in transgenic mdx mice: implications for gene therapy of Duchenne muscular dystrophy1995 · 157 citations